Our Programs

Our goal is to advance targeted treatments for cancer patients who need them the most. To accomplish this, we are focused on developing novel therapies that correct dysregulated gene expression of diseased cells and thereby inhibit cancer progression. Gene expression modulation is achieved by targeting proteins involved in regulating gene expression, i.e., epigenetic proteins and transcription factors.